ACT Announces Oregon Health & Science University As Clinical Trial Site for its Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration

MARLBOROUGH, Mass. — May 16, 2011 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the Casey Eye Institute (CEI) at Oregon Health & Science University (OHSU) in Portland, Ore., has received institutional review board (IRB) approval to be a site for its Phase 1/2 human clinical trial for Stargardt’s Myopia Macular degeneration (SMD)

Read More

What research chemistry has to offer?

Under the name research chemistry are considered research chemicals, substances used by scientists and ordinary people. Scientists use them in research purposes, ordinary people consume them. There are a lot of benefits of these chemicals here https://flakka.net, but since they haven’t yet been completely studied, you should be careful.